Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions

被引:227
作者
Bam, NB
Cleland, JL
Yang, J
Manning, MC
Carpenter, JF
Kelley, RF
Randolph, JW [1 ]
机构
[1] SmithKline Beecham, King Of Prussia, PA 19406 USA
[2] Genentech Inc, S San Francisco, CA 94080 USA
[3] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci,Ctr Pharmaceut Biotechnol, Denver, CO 80262 USA
[4] Univ Colorado, Dept Chem Engn, Ctr Pharmaceut Biotechnol, Boulder, CO 80309 USA
关键词
D O I
10.1021/js980175v
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the absence of surfactants, recombinant human growth hormone (rhGH) rapidly forms insoluble aggregates during agitation. The nonionic surfactant Tween 20, when present at Tween:protein molar ratios > 4, effectively inhibits this aggregation. Differential scanning calorimetry (DSC) of rhGH solutions showed melting transitions that decreased by ca. 2 degrees C in the presence of Tween. Circular dichroism (CD) studies of the same thermal transition showed that the decrease is specific to the relatively high protein concentrations required for DSC. CD studies showed melting transitions that decreased with lower protein concentrations. Tween has an insignificant effect on the melting transition of rhGH at lower protein concentrations (0.18 mg/mL). Injection titration microcalorimetry showed that the interaction of Tween with rhGH is characterized by a weak enthalpy of binding. For comparison, interferon-g, another protein which has been shown to bind Tween, also shows weak enthalpy of binding. Fluorescent probe binding studies and infrared spectroscopic investigations of rhGH secondary structure support suggestions in the literature (Bam, N. B.; Cleland, J. L., Randolph, T. W. Molten globule intermediate of recombinant human growth hormone: stabilization with surfactants. Biotechnol. Frog. 1996. 12, 801-809) that Tween binding is driven by hydrophobic interactions, with little perturbation of protein secondary structure.
引用
收藏
页码:1554 / 1559
页数:6
相关论文
共 29 条
[1]   STABILITY OF PROTEIN FORMULATIONS - INVESTIGATION OF SURFACTANT EFFECTS BY A NOVEL EPR SPECTROSCOPIC TECHNIQUE [J].
BAM, NB ;
RANDOLPH, TW ;
CLELAND, JL .
PHARMACEUTICAL RESEARCH, 1995, 12 (01) :2-11
[2]   Molten globule intermediate of recombinant human growth hormone: Stabilization with surfactants [J].
Bam, NB ;
Cleland, JL ;
Randolph, TW .
BIOTECHNOLOGY PROGRESS, 1996, 12 (06) :801-809
[3]   TECHNIQUES FOR ASSESSING THE EFFECTS OF PHARMACEUTICAL EXCIPIENTS ON THE AGGREGATION OF PORCINE GROWTH-HORMONE [J].
CHARMAN, SA ;
MASON, KL ;
CHARMAN, WN .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :954-962
[4]  
CLELAND JL, 1994, FORMULATION DELIVERY, V567
[5]  
DONG AC, 1994, METHOD ENZYMOL, V232, P139
[6]   THE STABILIZATION OF A HUMAN-IGM MONOCLONAL-ANTIBODY WITH POLY(VINYLPYRROLIDONE) [J].
GOMBOTZ, WR ;
PANKEY, SC ;
PHAN, D ;
DRAGER, R ;
DONALDSON, K ;
ANTONSEN, KP ;
HOFFMAN, AS ;
RAFF, HV .
PHARMACEUTICAL RESEARCH, 1994, 11 (05) :624-632
[7]  
Helenius A, 1979, Methods Enzymol, V56, P734
[8]  
JONES LS, 1997, THERAPEUTIC PROTEIN, P206
[9]  
KALE KM, 1979, BIOPOLYMERS, V18, P35
[10]   EFFECT OF SURFACTANTS ON THE PHYSICAL STABILITY OF RECOMBINANT HUMAN GROWTH-HORMONE [J].
KATAKAM, M ;
BELL, LN ;
BANGA, AK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (06) :713-716